Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹24.6 LAccepted-Finance | ₹24.6 L | L1 | Accepted-Finance L1 BIDDER |
| 2 | L1₹29.7 LAccepted-Finance SHOP NO 110A PRESTIGE POINT PREMISES CO OPERATIVE SOCIETY 283 SHUKRAWAR PETH PUNE PUNE MAHARASHTRA 411002 | PUNE | MAHARASHTRA | 411002 | ₹29.7 L | L1 | Accepted-Finance L1 BIDDER |
| 3 | L2₹6.2 LAccepted-Finance | ₹6.2 L | L2 | Accepted-Finance NOT A L1 BIDDER IN ANY ITEMS |
| 4 | L3₹6.7 LAccepted-Finance | ₹6.7 L | L3 | Accepted-Finance NOT A L1 BIDDER IN ANY ITEMS |
| 5 | L4₹20.2 LAccepted-Finance OFFICE NO 207 2ND FLOOR EAST END PLAZA EAST END PLAZA VASUNDHARA ENCLAVE NEW DELHI EAST DELHI DELHI 110096 | EAST DELHI | DELHI | 110096 | ₹20.2 L | L4 | Accepted-Finance NOT A L1 BIDDER IN ANY ITEMS |
Tender Value
Refer Docs
Closing Date
16 Jun 2021, 6:00 pmClosed
Brig R Ramprasad
AICTS,PUNE
Category I (Drugs/Vaccines Consumables)
2021_ARMY_450066_1
630/MS/DGLP/ECHS/OTE/50/21-22
Open Tender
Miscellaneous Goods
Supply
30 days
AICTS
Please refer Tender documents.
3 documents required · 3 mandatory
₹0
Exempted
15 Jul 2021
10 Jun 2021
17 Jun 2021
10 Jun 2021
16 Jun 2021
10 Jun 2021
10 Jun 2021 - 14 Jun 2021
Medicals Items :
Methyl Prednisolone Sodium Succinate 1000mg Inj
Piperacillin 4 gm +Tazobactum 500mg Inj
Enoxaparin 60 mg/0.6ml Inj
RIA PHARMACEUTICALS AND SURGICALS
M/S JAI GANESH PHARMACEUTICALS
SMPL Life Sciences Pvt. Ltd.
Arihant Meditech
AMBIKA DRUG HOUSE
Shri Vinayak Pharma
shreepal medicals
Arihant Meditech
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .